1. Home
  2. FGBI vs LENZ Comparison

FGBI vs LENZ Comparison

Compare FGBI & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Guaranty Bancshares Inc.

FGBI

First Guaranty Bancshares Inc.

HOLD

Current Price

$8.68

Market Cap

134.1M

Sector

Finance

ML Signal

HOLD

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$5.06

Market Cap

155.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FGBI
LENZ
Founded
1934
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
155.5M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
FGBI
LENZ
Price
$8.68
$5.06
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$44.00
AVG Volume (30 Days)
14.5K
708.4K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
0.44%
N/A
EPS Growth
N/A
N/A
EPS
0.31
N/A
Revenue
N/A
$19,088,000.00
Revenue This Year
$567.70
$50.42
Revenue Next Year
N/A
$197.16
P/E Ratio
$26.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.31
$4.54
52 Week High
$11.02
$50.19

Technical Indicators

Market Signals
Indicator
FGBI
LENZ
Relative Strength Index (RSI) 34.79 43.75
Support Level $7.83 $4.71
Resistance Level $9.24 $6.18
Average True Range (ATR) 0.33 0.36
MACD -0.04 0.03
Stochastic Oscillator 13.08 13.15

Price Performance

Historical Comparison
FGBI
LENZ

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana through several banking facilities. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and, to a lesser extent, consumer and multifamily loans. The company is engaged in a single line of business as a financial institution, which provides a full range of banking, financial, and trust services to state, county, and local government entities, individuals, and small and commercial businesses.

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.

Share on Social Networks: